Cargando…
Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
Ovarian cancer is the most lethal gynecological malignancy. Cisplatin and its derivatives are first-line chemotherapeutics, and their resistance is a major hurdle in successful ovarian cancer treatment. Understanding the molecular dysregulation underlying chemoresistance is important for enhancing t...
Autores principales: | Ali, Ahmed Y, Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499654/ https://www.ncbi.nlm.nih.gov/pubmed/23050965 http://dx.doi.org/10.1111/j.1749-6632.2012.06734.x |
Ejemplares similares
-
The Diarylheptanoid Hirsutenone Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin via Modulation of Apoptosis-inducing Factor and X-linked Inhibitor of Apoptosis
por: Farrand, Lee, et al.
Publicado: (2014) -
An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells
por: Farrand, Lee, et al.
Publicado: (2013) -
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022) -
Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003) -
Aging conundrum: A perspective for ovarian aging
por: Wu, Jiachen, et al.
Publicado: (2022)